DexCom, Inc. (DXCM) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:02 ET. Consensus EPS estimate is $0.66.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | FY2026 Q2 | $0.61 | $0.70 | +14.6% | $1.31B |
| 2026-04-30 | FY2026 Q1 | $0.47 | $0.56 | +20.3% | $1.19B |
| 2026-02-12 | FY2025 Q4 | $0.65 | $0.68 | +4.6% | $1.26B |
| 2025-10-30 | FY2025 Q3 | $0.58 | $0.61 | +5.9% | $1.21B |
| 2025-07-30 | FY2025 Q2 | $0.44 | $0.48 | +8.2% | $1.16B |
| 2025-05-01 | FY2025 Q1 | $0.33 | $0.32 | -2.2% | $1.04B |
| 2025-02-13 | FY2024 Q4 | $0.48 | $0.45 | -6.1% | $1.11B |
| 2024-10-24 | FY2024 Q3 | $0.44 | $0.45 | +2.3% | $994.20M |
DXCM has beaten consensus EPS in 6 of its last 8 reported quarters.
See DXCM on the live calendar →